Energy-based devices are one of the fastest-growing segments in aesthetics. According to IMARC Group, the global market for aesthetic lasers and energy devices was worth USD 6.8 billion in 2025 and is forecast to roughly double by 2034. But a growing market does not mean a specific device in your specific clinic will pay for itself. A purchase worth tens of thousands of euros should rest on one calculation: how many treatments per month this device needs to cover its own costs.
Demand is real, but unevenly spread
The ISAPS Global Survey 2024 counted 20.5 million non-surgical and 17.4 million surgical procedures worldwide. Two of the top five non-surgical categories are device-driven: hair removal and non-surgical skin tightening. Right next to them, though, sit botulinum toxin and hyaluronic acid fillers, which need no expensive equipment at all.
US data, the largest market in the survey, shows how wide the gap is:
The takeaway for a clinic owner: a device competes for calendar time and patient budget with injectables that have a much lower barrier to entry. A laser does not earn because "the market is growing". It earns because your patients book it, repeatedly.
Three numbers decide your payback
The whole calculation comes down to three values, and you can pull each one from your own data.
| Value | What it includes | Where to find it |
|---|---|---|
| Monthly fixed cost of the device | lease or loan instalment, service contract, insurance, licences, launch ad budget | lease agreement, service quote, marketing plan |
| Contribution margin per treatment | price minus consumables, practitioner pay, commissions | price list and payroll |
| Available slots | calendar windows where both the device and a trained operator are free | your clinic calendar |
Break-even (treatments/month) = monthly fixed cost ÷ margin per treatment
Required utilisation = break-even ÷ available slots per month
The second number matters more than the first. A break-even of 20 treatments a month sounds easy until you realise the device only has 40 real windows, because the one trained operator works three days a week.
A worked example, step by step
The figures below are assumptions used only to illustrate the method. Replace them with numbers from your own lease offer and price list.
- Fixed cost: instalment 900 + service 100 + insurance 25 + launch ads 375 = 1,400 per month.
- Margin per treatment: price 100 − consumables 5 − practitioner pay 17.5 = 77.5.
- Break-even: 1,400 ÷ 77.5 = 18.1, so 19 treatments per month.
- Available slots: 5 treatments a day × 20 days = 100 slots.
- Required utilisation: 19 ÷ 100 = 19% of the device's calendar just to break even.
Now stress-test it. If a promotion cuts the price by 20% (to 80), the margin drops to 57.5 and break-even rises to 25 treatments. If the operator leaves and only 50 slots remain, the same device now needs 50% utilisation. That second scenario is more common than owners expect, and it is worth modelling before you sign.
Lease, buy outright or rent: a decision matrix
In Poland, leasing is the dominant way to finance equipment. According to the Polish Leasing Association (ZPL), leasing companies financed PLN 119.5 billion of assets in 2025, and 70.9% of that went to small and medium-sized businesses.
The right financing route depends on how certain your demand is:
| Clinic situation | Recommended route | Why |
|---|---|---|
| You have a waiting list or refer patients elsewhere | Buy or lease | demand is proven; only the cost of finance matters |
| You get enquiries but don't know the real conversion rate | Day rental or a short lease | test demand without locking capital for five years |
| The treatment is new in your local market | Test campaign and a waiting list first | validate demand before buying hardware |
| Small business with a strong year (Poland) | Outright purchase with one-off depreciation | faster tax deduction of the cost |
Tax rules matter too. In Poland, a small taxpayer can write off fixed assets in groups 3-8 in a single year up to EUR 50,000, which is PLN 213,000 in 2026. It counts as de minimis state aid, so check it with your accountant first. Outside Poland, ask your adviser about the local equivalent.
Pre-signing checklist
- Demand from data, not gut feel: how many people asked about this treatment in the last six months? If you don't know, start logging enquiries in your CRM.
- Who will operate it: do you have at least two trained people? One operator is one resignation away from an idle device.
- Slots, not opening hours: count the windows when device and staff are available at the same time.
- Packages and series: device treatments usually come in courses. Every package sold books several future slots.
- Patient acquisition cost: add a launch ad budget to your fixed costs. Nobody searches for a new treatment at your clinic on their own.
- A 90-day launch plan: how many existing patients can you invite? Your current patient base is the cheapest launch channel.
- Pessimistic scenario: run break-even at a 20% lower price and half the slots. If the result is negative, you need a cash buffer.
How to track payback after purchase
The pre-purchase maths is only half the job. Once the device is live, check three metrics every week: treatments performed on it, slot utilisation, and packages sold. Weekly, not quarterly, because a drop in utilisation shows up in the calendar long before it shows up in your P&L.
Track where patients for the new treatment come from as well. If most come from your existing patient base rather than ads, your acquisition cost is lower than planned and your real break-even falls.
FAQ
How many treatments a month does a laser need to pay for itself?
It depends on your costs and margin. Divide the device's monthly fixed cost (instalment, service, insurance, ads) by the margin on one treatment. With a fixed cost of 1,400 and a margin of 77.5, you need 19 treatments a month.
Should I lease or buy outright?
If demand is proven, the difference comes down to finance costs and tax. If demand is uncertain, consider renting the device by the day or a shorter agreement, so you don't tie up capital for years.
Can I depreciate the device in one year?
In Poland, small taxpayers and new businesses can write off group 3-8 fixed assets in one year up to PLN 213,000 in 2026. It is de minimis aid, so confirm eligibility with your accountant. Rules differ in other countries.
What utilisation level is safe?
A safe plan reaches break-even using a small share of available slots, with the rest as profit. If you need more than half your slots just to break even, every holiday or staff departure turns into a loss.
Summary
Buying a device is a decision built on three numbers: fixed cost, margin per treatment and available slots. All three can be calculated before you sign and tracked every week afterwards. Palyri brings your calendar, patient enquiry history and package sales into one place, so device utilisation and real demand for a treatment are visible as they happen, not in the year-end report.
Sources
- ISAPS, Global Survey 2024 press release, 2025
- ISAPS, Global Survey 2024 full report, 2025
- American Med Spa Association, ISAPS 2024 US data, 2025
- IMARC Group, Aesthetic Lasers and Energy Devices Market, 2025
- Bank.pl / Polish Leasing Association, 2025 industry results, 2026
- PIT.pl, One-off depreciation EUR 50,000 limit, 2026
Want to implement this in your clinic?
Book a free Palyri demo. We'll show how it works on your clinic's data.
Book demo via WhatsAppPaulina Zielińska
Konsultant w branży beauty
Ponad 4 lata doświadczenia w branży beauty: najpierw od środka jako manager kliniki, teraz jako niezależny konsultant. Wdrożyła systemy automatyzacji sprzedaży i CRM w kilkudziesięciu klinikach estetycznych w Polsce.